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Abstract
The conserved role of Notch signaling in controlling intestinal cell fate specification and homeostasis has been extensively
studied. Nevertheless, the precise identity of the cells in which Notch signaling is active and the role of different Notch
receptor paralogues in the intestine remain ambiguous, due to the lack of reliable tools to investigate Notch expression and
function in vivo. We generated a new series of transgenic mice that allowed us, by lineage analysis, to formally prove that
Notch1 and Notch2 are specifically expressed in crypt stem cells. In addition, a novel Notch reporter mouse, Hes1-EmGFP
SAT,
demonstrated exclusive Notch activity in crypt stem cells and absorptive progenitors. This roster of knock-in and reporter
mice represents a valuable resource to functionally explore the Notch pathway in vivo in virtually all tissues.
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Introduction
Extensive work on the mouse intestine established the existence
of a multipotent cell population that has the capacity to regenerate
throughout life and is responsible for the rapid and continuous
renewal of the intestinal epithelium [1]. Through the identification
of specific cellular markers, two stem cell populations have been
identified in distinct positions within the intestinal crypts. Lgr5
positive stem cells, also referred to as crypt base columnar (CBC)
cells, dwell at the bottom of the crypt, intercalated with
differentiated Paneth cells in the small intestine [2]; Bmi1 positive
stem cells are predominantly located just above the Paneth cell
compartment and are referred to as ‘‘+4 cells’’, indicating their
position from the bottom of the crypt [3]. Both stem cell
populations are actively cycling and show similar developmental
multipotency and long-term regeneration potential, but have
distinct cell cycle requirements. CBC cells are extremely sensitive
to the loss of CDC25 function, a cell cycle protein controlling cell
proliferation, and respond by undergoing differentiation prema-
turely, while +4 cells remain insensitive [4]. The existence of a
third kind of stem cells, slowly cycling or quiescent, has also been
recently reported, but their biological properties have yet to be
characterized [5]. It is thought that stem cells give rise to short-
lived transit-amplifying progenitors, which undergo a limited
number of divisions while apically migrating. These are still
uncommitted crypt cells that will eventually give rise to the fully
differentiated intestinal lineages.
The Notch signaling pathway is a major regulator of cell fate in
metazoan development, linking the fate of one cell to that of a
cellular neighbour. This is achieved through the interaction of
membrane-bound ligands in one cell to the Notch surface receptor
expressed on an adjacent cell. A wealth of studies implicated
Notch signalling in controlling the fate of early precursors, indeed
stem cells, in many different organs [6,7,8], so that it is now
recognized as a major player in various aspects of stem cell
biology, including their maintenance and differentiation [9]. In the
intestine, we and others have shown that Notch signals are
essential in maintaining tissue homeostasis and continuous
renewal. While abolishing Notch signaling induces an arrest of
crypt cell division and the conversion of crypt progenitors into
secretory cells [10,11,12], constitutive activation of Notch1 leads
to a dramatic increase in the number of proliferating cells in the
intestinal epithelium, accompanied by impairment of differentia-
tion [13].
Notwithstanding the clear implications of Notch signaling in
intestinal stem cell homeostasis, it is unclear which of the four
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whether Notch expression marks multipotent stem cells, or
lineage-restricted precursors. Indeed the specific role of Notch
paralogues is an aspect of Notch biology that is not well
understood and the reagents to rigorously address this question
are lacking.
Here, we set out to formally assess the expression and activity
of Notch receptors in intestinal stem cells in vivo u s i n gar o s t e ro f
new transgenic mice we have generated, that allow fate
mapping of specific cell lineages whose precursors express
specific Notch receptor paralogues, as well as monitoring
signaling activity using Notch reporter mice. The value of the
transgenic strains we generated is demonstrated in this study for
the intestine, where we show that both Notch1 and Notch2
receptors are specifically expressed in crypt stem cells. Using a
Notch activity reporter mouse, we also ascertain that Notch
signaling is active in intestinal stem cells, as well as in
absorptive progenitors, while in cells destined to adopt a
secretory fate, and in terminally differentiated cells, Notch
activity is undetectable.
Figure 1. Notch1 and Notch2 expression in the small intestine. X-gal staining (blue) of thin sections of proximal small intestine of N1-
CreERT2
SAT/+;R26R/+ (A) and N2-CreERT2
SAT/+;R26R/+ (B) 24 hours after tamoxifen administration shows that Notch1 and Notch2 are expressed only
in the intestinal crypts. C–D) In situ hybridization for Notch1 (C) and Notch2 (D) demonstrates specific expression in intestinal crypts. E–F) Whole
mounts duodenum of N1-CreERT2
SAT/+;R26R/+ (E) and N2-CreERT2
SAT/+;R26R/+ (F) 7 months after tamoxifen administration demonstrates long-term
labeling of X-gal marked Notch lineages. Counterstain: hematoxylin/eosin in A. Scale bar: 50 mm in A–D and 1 mm in E–F.
doi:10.1371/journal.pone.0025785.g001
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Cre gene targeting for Notch paralogue-specific
expression
In order to establish the identity of the cells expressing the
different Notch receptors and eventually trace their lineage, we
generated four transgenic lines in which the Cre-estrogen receptor
binding domain fusion (Cre-ER) [14] is knocked-in into the first
exon of each of the four Notch receptor paralogues (N1 through
N4, henceforth referred to as N1-CreERT2
SAT, N2-CreERT2
SAT,
N3-CreERT2
SAT and N4-CreERT2
SAT). In each of the four lines,
one allele of the targeted Notch locus expresses the tamoxifen
inducible Cre-ER recombinase under the control of the respective
Notch paralogue promoter, while the other allele remains
functional (Figure S1A). All lines are viable and fertile as
heterozygotes, whereas homozygous N1-CreERT2
SAT and N2-
CreERT2
SAT mice die during embryogenesis, as described for
their respective knock-outs [15,16].
We validated the four N(1–4)-CreERT2
SAT knock-in lines by
crossing them to a Rosa26 LacZ reporter strain (R26R) [17].
Adult N(1–4)-CreERT2
SAT/+; R26R/+ and control N(1–4)-
CreERT2
SAT/+ mice were induced with a single dose (50 mg/
kg of mouse body weight) of 4-Hydroxytamoxifen (4-OHT) and
analyzed after 24 hours. Tissue samples from adult bi-genic and
control mice were visualized for b-galactosidase expression in
order to detect the cells that had undergone recombination. Our
results in heart, liver and brain corroborate and extend previous
reports for Notch receptor distribution in these tissues
[18,19,20,21], and indicate that the Cre recombinase is indeed
expressed according to the expression pattern of the four Notch
paralogues (Figure S1B–K).
Notch receptor expression is associated with crypt stem
cells
The ability to conditionally mark Notch-expressing cells allows
us to follow the cell lineages associated with each Notch receptor
paralogue expression and thus we used these transgenic tools to
examine the expression of Notch receptors in the intestine and
their relationship to the renewal of this tissue in adult mice.
Following induction of 4 week-old N(1–4)-CreERT2
SAT/
+;R26R/+ double transgenic mice with one pulse of tamoxifen
(50 mg/kg of body weight), Notch1 and Notch2 mark exclusively
epithelial crypt cells of the adult small intestine, when examined
12, 18 and 24 hours after tamoxifen administration (Figure 1A–B),
in agreement with in situ hybridization results (Figure 1C–D).
Conversely, Notch3 and Notch4 are not expressed in the gut
epithelium but in the endothelial and mesenchymal cells
surrounding it (data not shown). This analysis also revealed that
far fewer cells express Notch2 than Notch1.
Three days after tamoxifen induction, we detected marked
progeny of Notch-expressing cells outside the crypt, in differen-
tiated villus cells (Figure 2A,D); labeled clones formed continuous
streams of cells vertically aligned to the crypt-villus axis and
reached the villus top by seven days (Figure 2B), consistent with
the kinetics of cell replacement in the intestine. Importantly, b-
galactosidase positive cells persisted for 30 days, 60 days
(Figure 2C,F) and even 7 months after a single tamoxifen
induction (Figure 1E–F), continuing to give rise to differentiated
progeny, indicating labeling of long-lived intestinal stem cells
endowed with self-renewal capacity. All experiments indicate that
while both Notch1 and Notch2 mark stem cells, the incidence of
Notch1-expressing cells is far greater (as clearly illustrated in whole
mount pictures in Figure 1E–F).
Identification of Notch lineages in the intestine
In order to corroborate our findings with the R26R reporter
strain, we crossed N(1–2)-CreERT2
SAT mice to a recently
developed Cre-sensitive double fluorescent reporter line,
R26
mTmG [22]. In N(1–4)-CreERT2
SAT/R26
mTmG mice, the
membrane-associated tomato fluorescent protein (mT) is expressed
in all cells until tamoxifen injection, after which membrane-
associated GFP (mG) marks cells targeted by Cre recombination.
The availability of the two strains offered the possibility to
corroborate our results in two distinct genetic backgrounds: in the
absence of tamoxifen treatment, reporter expression was not
detected in both double transgenic mice, indicating absence of
leakiness.
To score the location of the crypt cells expressing the two Notch
receptors, we reduced the tamoxifen dose to 5 mg/kg of mouse
body weight, which allowed us to theoretically label a single cell
per crypt. At this low tamoxifen dose, approximately 30% of the
total crypts harbor labeled cells. We proceeded counting crypts
harboring a single marked cell (an example of a ‘‘scorable’’ crypt is
shown in Figure 3A) and classified its localization as ‘‘CBCs’’ or
‘‘+4 cells’’, as exemplified in Figure 3B. While, as expected from
the above analysis, we very rarely succeeded in identifying Notch2
positive crypt cells, preventing rigorous statistical analysis, the
position of the Notch2-positive cells identified could not be
distinguished from the position of the Notch1-positive cells. As
presented in the pie graph in Figure 3C, we find Notch1-
expressing cells predominantly in the +4/+5 position, though
approximately 30% of marked cells are also found as CBC cells
intermingled among Paneth cells. By topological and morpholog-
ical criteria alone, therefore, Notch1 appears to be expressed in
both crypt stem cell sub-populations.
Mapping the fate of Notch1-expressing crypt cells revealed that
Notch1 is indeed expressed in multipotent cells able to generate all
four differentiated cell types of the intestine (Figure 4). The
extreme longevity of Notch1-expressing cells in a tissue where
almost complete cell renewal is normally achieved in a week, along
with their multipotency, has allowed us to confirm that Notch1 is
expressed in vivo in long lasting intestinal stem cells.
The analysis of the Notch1 lineage in the different tracts of the
intestinal tube, shows a striking proximal to distal descending
gradient in the small and large intestine, with highly abundant
Notch1 lineage in the proximal duodenum and fewer labeled cells
in the distal parts of the ileum and in the colon (Figure S2), as
previously reported [10,23,24]. This spatial gradient probably
reflects regional differences in Notch1 expression in the intestine,
but it may also result from a lower efficiency in stem cell labeling
in the distal bowel due to a slower division rate of colonic stem
cells [2] or to decreased tamoxifen availability in the colon.
Clonal dynamics of Notch 1 expressing stem cells
If indeed the Notch receptor marks genuine stem cells, we
expected Notch cell lineages to show a dynamic profile compatible
with the reported behavior of intestinal stem cells [25,26].
Examining the populations kinetics of Notch1-expressing cells at
different time points after Cre induction showed that the
percentage of marked crypts gradually decreases over time when
we used a diluted dose of tamoxifen (5 mg/kg of mouse body
weight), eventually stabilizing around 2% within 60 days (see
graph in Figure 3D).
It has been calculated that each crypt contains 14 to 16 stem
cells [26], but only one of them generates the entire crypt progeny,
a phenomenon termed monoclonal conversion [27,28,29]. Wich
stem cell will eventually clonally repopulate the crypt is stochastic
event [25,26] founded on neutral competition between equipotent
Notch Lineages in the Mouse Intestine
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reflects then 1/16 (6%) chance of labeling the cell that will
generate the entire crypt, assuming that there are 16 stem cells per
crypt. Given that 30% of all crypts are marked, we anticipated that
only 6% of those would eventually give rise to fully labeled crypts
during monoclonal conversion. Our finding therefore of a gradual
decrease in the number of Notch marked crypt cells over time with
a plateau of about 2% (Figure 3D) is in good agreement with what
we would expect if the Notch receptor was expressed in the crypt
stem cells.
When we examined the dynamics associated with the
monoclonal conversion of marked crypts in relation to time after
tamoxifen induction, we found a progressive increase in the
number of fully labeled crypts as the chase time increases, reaching
about 90% by 60 days (Figure 3E–G). Such behavior is expected
from previous reports examining stem cell lineages and can be
satisfactorily described by the neutral drift equations utilized
broadly in population genetics [30]. We found that the stem cell
replacement rate lambda is equal to 1.32/day, a value consistent
with previous findings in the crypt [25,26]. This analysis clearly
associates Notch expression with long-lived intestinal stem cells.
Notch signaling is active in crypt stem cells and is
permissive for enterocyte differentiation
Given that expression of the Notch receptor cannot be equated
to Notch signal activation, it was important to assess whether cell
populations that express Notch receptors actually signal. To this
end, we generated and used a novel Hes1-EmGFP
SAT reporter
mouse, in order to monitor Notch activity in vivo at a single cell
level. In these mice, the expression of emerald GFP is under the
control of the endogenous promoter of the Notch target gene Hes1
(Figure 5A). Analysis of the adult intestine of Hes1-EmGFP
SAT
mice showed that undifferentiated crypt cells, including stem cells
and progenitors, express high levels of Hes1 (Figure 5B), while
GFP fluorescence is completely absent from all secretory cell types:
Paneth, enteroendocrine and Goblet cells (Figure 5E–G). Some
GFP expression is also detected in differentiated enterocytes in the
villus compartment, although at significantly lower levels com-
pared to crypt cells (see Figure 5B). This could result from
persistence of GFP protein due to high protein stability, possibly
suggesting that residual Notch activity is present in progenitor cells
adopting an absorptive fate, or it may indicate that other pathways
may activate the Hes1 promoter in enterocytes. In an attempt to
examine if the enterocyte fluorescence reflects active Notch
signaling, we then treated Hes1-EmGFP
SAT mice with the
pharmacological Notch inhibitor dibenzazepine (DBZ) and were
able to show that the residual GFP signal observed in the villi does
not depend on active Notch signaling. Indeed, while GFP
fluorescence in the crypts is completely abolished in DBZ-treated
mice, detectable levels in the villi are unchanged by Notch
inhibition (Figure 5C–D). These results are consistent with the
absence of active Notch signaling in terminally differentiated villus
cells. Given that the Hes1 protein is not detected in the villus
compartment [12,13,31,32], we conclude that the observed
residual GFP signal is due to persistence of the GFP protein in
the progeny of absorptive progenitor cells.
Figure 2. Tracing of Notch1 and Notch2 lineages shows stem cell labeling. Four week-old N1-CreERT2
SAT/+;R26R/+ (A–C) and N2-
CreERT2
SAT/+;R26R/+ (D–F) mice were injected with tamoxifen and analyzed for b-galactosidase expression (blue) after 3 days (A,D), 7 days (B,E) and
60 days (C,F). The lineage of Notch1-expressing cells is shown in thin longitudinal sections in A and C and in whole mounts in B to better visualize
continuous streams of labeled cells. Sections are counterstained with hematoxylin/eosin in C–F. Scale bar: 40 mm in A,D,E; 50 mm in B and 80 mmi n
C,F.
doi:10.1371/journal.pone.0025785.g002
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The generation of a new set of Notch transgenic mice allowed
us a dissection of cell lineages associated with Notch receptor
expression and activity in the intestine in an unprecedented
manner. The data we obtained indicate that the Cre recombinase
inserted into the first exon of each of the four Notch receptor
paralogues is expressed in a pattern faithfully reflecting the
endogenous expression of each receptor. While the gamut of
tissues examined thus far is limited, the detailed characterization of
the expression pattern in the intestine at the single cell level
indicates that these reagents can be widely and ubiquitously used
to examine Notch expression and, most importantly, allow the
analysis of Notch lineages. Moreover, the Hes1 reporter we
generated seems to accurately report Notch signaling activity in
the intestine. We thus anticipate that the collection of transgenic
reagents we generated will be broadly useful.
The importance of Notch signaling in intestinal renewal and
differentiation, as well as in affecting tumor development in this
tissue, is exemplified by the vast number of reports and reviews on
this topic that appeared within the last few years (i.e.
[10,11,12,13,24,31,33,34,35,36]). Our results formally establish
the specific expression of Notch1 and Notch2 in intestinal stem
cells in vivo and ascertain that the pathway is indeed functional in
these cells. While it is clear that Notch1 labeling is far more
prominent than Notch2, the limitations of the Cre-mediated
recombination method of marking cells do not allow us to
determine if this difference is due to the relative expression levels
of Notch1 and Notch2 or whether the two receptors mark distinct
stem cell populations. Notch1 and Notch2 have been previously
found to have redundant functions in the intestine, using
conditional knockout mice for either one of the two receptors
[11]. On the other hand, Wu et al. recently reported that the
specific inhibition of Notch1, but not Notch2, by antagonistic
antibodies is sufficient to reveal a partial Notch loss of function
phenotype in the intestinal crypt, characterized by a decrease of
proliferative cells and an increase of secretory goblet cells [37].
Our expression data show that while Notch1 expression is
predominant in the proximal small intestine (Figure S2), Notch2
marks more efficiently cells in the distal tracts (data not shown).
The regional differences we observe could therefore account for an
overlapping, yet not completely redundant function of the two
Notch receptors in the intestinal epithelium. This would be of
importance as it is widely assumed that the specificity of the
Notch1 and Notch2 receptors are equivalent, albeit displaying
non-identical ‘‘pharmacologies’’. Given the extraordinary sensi-
tivity of cells to the dosage of Notch signaling activity [38,39],
subtle differences in the expression profiles of these two receptors
may translate into distinct and developmentally significant
signaling levels.
Activation of Notch signaling in intestinal stem cells has recently
been described using a Notch1 activation-dependent knock-in
mouse line, NIP1::CreERT2 [10]. In this study, stem cell labeling
has been indirectly assessed, by analyzing the progeny of cells in
Figure 3. Kinetics of stem cell replacement and monoclonal conversion of Notch1-expressing cells. To define the localization of Notch1-
expressing crypt cells, only crypts harboring a single marked cell were scored, as shown in A. Cells were classified as ‘‘CBCs’’ (marked by white
arrowheads in B), ‘‘+4’’ (indicated by a white arrow in B) or ‘‘other’’ when it was not possible to clearly assign their position. In B, N1-CreERT2
SAT/
+;R26
mTmG/+ mice were injected with tamoxifen at 4 weeks and analyzed 24 h after induction. Genetically marked cells show membrane-bound
green fluorescence (GFP), while membrane-anchored Tomato (red) fluorescence is present in non-recombined cells. C: graphic view of the
quantification of labeled cells. At least five fields from a single intestine were counted and at least three mice per time point (12 h, 18 h, 24 h) were
scored independently by two researchers. The total number of crypts counted was 1095. D) Marked crypts were counted at different time points after
tamoxifen injection (x axis). The Y axis represents the percentage of labeled crypts over the total crypt population. E) Graphic representation of the
percentage of fully labeled (dark blue) or mosaic crypts (light blue) among the population of marked crypts. F) Data of the monoclonal conversion of
marked crypts (dots), compared with a fit (straight line), applying the neutral drift theory [17]. The only fitting parameter is the stem cell renewal rate
l=1.3260.05/day. G) Representative cross section of 60 days chase showing fully labeled (all blue), partially labeled and non-recombined (pink)
crypts used to quantitatively evaluate the monoclonal conversion kinetics. Counterstain: hematoxylin and eosin. Scale bar: 10 mmi nA ,B .
doi:10.1371/journal.pone.0025785.g003
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administration. When we assessed Notch transcriptional activity
in vivo at the time of dissection, using the Hes1-EmGFP
SAT
reporter line, we observed GFP label in stem cells, but also in villus
enterocytes, albeit at a lower intensity than in crypt cells. These
observations are consistent with our previous findings showing that
constitutively active Notch in adult mice blocks secretory cell
differentiation, but it is permissive for the absortive cell fate
[12,31,34]. We can thus extrapolate that Notch signaling is indeed
active in crypt stem and possibly enterocyte progenitor cells.
The absence of Cre recombination in villus enterocytes in N1-
CreERT2 mice may be explained by very low activity of the
Notch1 promoter in these cells, not sufficient to reach the
threshold for Cre-mediated recombination. Indeed, Kopinke and
colleagues recently reported the expression of Hes1 in the
intestinal crypt using a Hes1-CreERT2 mouse and found that
Hes1 marks single cells at the crypt base or at the crypt-villus
junction, but observed no label in the villus compartment [24].
Taken together, these combined results suggest that high levels of
Notch signals are operating in crypt stem cells, whereas low
signaling levels, below the Cre activation threshold, may be
present in progenitor cells and may be important to funnel these
cells to the enterocyte fate. Residual GFP label found in
differentiated enterocytes in the villus may be due to persistence
and dilution of GFP upon cell division of absortive progenitors due
to high protein stability, as suggested by the fact that villus GFP is
not changed by blockage of Notch activity in vivo.
Even if it is clear that Notch1 marks intestinal stem cells, the
possibility that it may also be expressed in short-lived progenitor
cells warrants some consideration. When we analyzed clonal
dynamics, we observed that the percentage of marked crypts does
not monotonously decrease during the first week, as the neutral
drift theory would predict (no significant change between 3 days
and 7 days in Figure 3D). If crypts with one labeled stem cell also
contained some marked short-lived progenitors, the crypts where
marked stem cells are replaced by neutral competition with
unlabeled stem cells would still appear blue in the first week, even
though they will eventually be monoclonally converted to white
crypts. This behavior prompts us to consider the possibility that
Notch1 may also mark short-lived progenitor cells, an option that
would be compatible with the estimated progenitor renewal rate,
suggested to be approximately 7 days [33]. In this context, it is
worth noting that the insertion of the CreERT2 cassette in the
Notch1–4 loci creates a null allele. Even if Notch1 and Notch2
heterozygous mice do not display any appreciable differences from
wild type animals, the possibility that crypt stem cells carrying one
functional Notch allele may behave slightly differently than wild
type cells cannot be rigorously ruled out on the basis of our
analysis.
This study indicates that Notch signaling is required to maintain
multipotent stem cells in the intestine, while our previous studies
established that Notch activation might affect the proliferative
potential of stem cells [13]. These results emphasize the central
role of Notch in the maintenance of intestinal stem cells and are
compatible with our findings that the synergy between Notch
activation and other oncogenic stimuli is involved in the initiation
of neoplastic conditions in this tissue [31].
Materials and Methods
Ethics statement
All studies and procedures involving animals were in strict
accordance with the Harvard’s Institutional Animal Care and Use
Committee (IACUC), the Institutional Animal Care and Use
Committee at Yale School of Medicine as well as French and
European legislations for the ‘‘Protection of Vertebrate Animals
Figure 4. Notch1-expressing cells in the intestine are multipotent. N1-CreERT2
SAT/+;R26
mTmG/+ mice were analyzed 30 days after tamoxifen
administration. Notch1-expressing crypt cells give rise to all four differentiated cell types of the intestine, as illustrated by the concomitant labeling of
membrane-tagged GFP (Notch progeny in green) and A-A9) UEA1 staining (red) marking Goblet cells indicated by the arrows; B-B9) anti-lysozyme
staining (red) recognizing Paneth cells; C-C9) anti-villin staining (red) marking the apical brush border of enterocytes; and D-D9) anti-chromogranin
immuno-labeling (red) revealing the position of enteroendocrine cells (indicated by a white arrowhead in D). A9–D9 show higher magnifications of the
four cell types presenting both membrane-tethered green and red fluorescence. Nuclei are marked in blue with DAPI. Scale bar: 50 mm in A–D; 10 mm
in B9 and 5 mmi nA 9,C 9 and D9.
doi:10.1371/journal.pone.0025785.g004
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approved by the Departmental Direction of Populations Protec-
tion (approval number: B75-05-18). Husbandry, supply of animals
as well as maintenance and care of the animals in EOPS (Exempt
Of Pathogen Species) environments before and during experi-
ments fully satisfies the animal’s needs and welfare. Suffering to the
animals has been kept to a minimum; no procedures inflicting pain
have been performed.
Generation of Notch(1–4)-CreERT2
SAT and Hes1-
EmGFP
SAT constitutive Knock-in mice
Notch(1–4)-CreERT2
SAT constitutive Knock-in mice. Targe-
ting vectors were based on 9.2 to 10.0 kb genomic fragments
covering the promoter region (Notch1–4), exon 1 (Notch1–4),
exon 2 (Notch1,3), exon 2–8 (Notch4) and surrounding
sequences. The four individual genomic fragments obtained
from a C57Bl/6J RP23 BAC library were modified in a similar
fashion by replacing the exon 1 region between the translation
inititation site and the end of exon 1 with a cassette containing
the CreERT2 open reading frame, a polyadenylation signal and
an FRT-flanked Neomycin resistance gene.
Hes1-EmGFP
SAT constitutive Knock-in mice. The targe-
ting vector was based on a 10.2-kb genomic fragment from the
Hes1 gene encompassing exons 1 to 4 and surrounding sequences.
This fragment, obtained from a C57Bl/6J RP23 BAC library, was
modified by replacing the genomic region from the translation
initiation site in exon 1 to exon 3 with a cassette containing the
EmGFP open reading frame, a polyadenylation signal and an
FRT-flanked Neomycin resistance gene. A Thymidine Kinase (Tk)
cassette was inserted at the 39 end of the genomic fragment to
allow for ganciclovir selection of ES cell clones displaying
homologous recombination events.
ES cell culture. The quality tested C57BL/5NTac ES cell
line was grown on a mitotically inactivated feeder layer comprised
of mouse embryonic fibroblasts (MEF) in DMEM High Glucose
medium containing 20% FBS (PAN Biotech GmbH) and 1200 u/
mL Leukemia Inhibitory Factor (Millipore ESG 1107). 1610
7 cells
and 30 mg of linearized DNA targeting vector were electroporated
Figure 5. Expression of the Notch transcriptional target Hes1 in the intestine. A) Schematic representation of the targeted Hes1 locus in
the Hes1-EmGFP
SAT reporter line. Hes1-EmGFP
SAT mice were analyzed for GFP expression in frozen sections (B–G). DBZ-treated animals (D) show
absence of Hes1-EmGFP expression in crypt cells, while the signal in the villus compartment is unaltered by Notch inhibition, as compared to
untreated mice (B and C). Immunofluorescent labeling of secretory cells reveals the complete absence of GFP label from differentiated secretory cells,
detected by anti-mucin antibodies for Goblet cells (red) in E, anti-lysozyme staining for Paneth cells (red) in F (see also the absence of green
fluorescence in Paneth cells in the inset B9) and anti-chromogranin staining for enteroendocrine cells and (red) in G. Nuclei are marked in blue with
DAPI in C–G. Scale bar: 100 mmi nB ;1 0mmi nB 9;8 0mm in C–D and 40 mm in E–G.
doi:10.1371/journal.pone.0025785.g005
Notch Lineages in the Mouse Intestine
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25785(Biorad Gene Pulser) at 240 V and 500 mF. Upon appropriate
selection resistant colonies with a distinct morphology were
isolated on day 9 after transfection and expanded in 96well
plates. Correctly recombined ES cell clones were identified by
Southern Blot analysis using external and internal probes and were
frozen in liquid nitrogen.
Generation of mice. The animal study protocol was
approved according to the German Animal Welfare Act by the
local authority. Mice were kept in the animal facility at
TaconicArtemis GmbH in microisolator cages (Tecniplast
Sealsave). Feed and water were available ad libitum. Light cycles
were on a 12:12 h light:dark cycle with the light phasing starting at
06:00 h. Temperature and relative humidity were maintained
between 21 and 23uC and 45 and 65%.
After administration of hormones, superovulated BALB/c
females were mated with BALB/c males. Blastocysts were isolated
from the uterus at dpc 3.5. For microinjection, blastocysts were
placed in a drop of DMEM with 15% FCS under mineral oil. A
flat tip, piezo actuated microinjection-pipette with an internal
diameter of 12–15 micrometer was used to inject 10–15 targeted
C57BL/6NTac ES cells into each blastocyst. After recovery, 8
injected blastocysts were transferred to each uterine horn of 2.5
days post coitum, pseudopregnant NMRI females. Chimerism was
measured in chimeras (G0) by coat colour contribution of ES cells
to the BALB/c host (black/white). Highly chimeric mice were
bred to C57BL/6-Tg(CAG-Flpe)2Arte females mutant for the
presence of the Flp recombinase gene. This allowed detection of
germline transmission by the presence of black, strain C57BL/6,
offspring (G1) and creation of selection marker deleted constitutive
Knock-in mice by Flp-mediated removal, in one breeding step.
Genotyping of mice by PCR. Genomic DNA was extracted
from tail tips using the NucleoSpin Tissue kit (Macherey-Nagel)
and was analyzed by PCR in the presence of 2.0 mM MgCl2,
200 mM dNTPs, 100 nM of each primer, and 2 U of Taq DNA
polymerase (Invitrogen) with the following primers detecting
heterozygous or homozoygous Knock-in alleles:
Notch1: 1228_23: ATAGGAACTTCAAAATGTCGCG
1289_31: CACACTTCCAGCGTCTTTGG (312 bp KI)
Notch2: 1228_23: ATAGGAACTTCAAAATGTCGCG)
1270_23: CCCAACGGTGCCAAAAGAGC (513 bp KI)
Notch3: 1228_23: ATAGGAACTTCAAAATGTCGCG
1239_22: CCCAGCTGCTGCATCTCTGC (187 bp KI)
Notch4: 1228_23: ATAGGAACTTCAAAATGTCGCG
1273_28: GGCTTCTCCCTGGGCATGG (276 bp KI)
Hes1: 1487_35: CCCAAGTTCGGGTGAAGGC
1487_36: CCTTGGACAATGCCACCCAA (396 bp KI)
The Rosa26R and R26
mTmG reporter lines have been
previously described [17,22] and were obtained by the Jackson
Laboratories.
Histology, In Situ Hybridization, Immunofluorescence
Labeling, and ß-Galactosidase Assay
Tissues were fixed and immunostained as previously described
[31]. Immunofluorescence was performed on OCT-embedded
frozen sections (5 mm), while immunohistochemistry on paraffin
sections (5 mm) of intestines fixed in 4% paraformaldehyde (PFA)
for 2 hours at room temperature. Where indicated, sections were
counterstained with Hematoxylin and Eosin (Vector Laboratories),
Nuclear Fast Red (Vector Laboratories) or PAS (Periodic Acid
Schiff, VWR). For fluorescence staining, nuclei were stained with
DAPI.
The primary antibodies used were: rabbit anti-lysozyme (cat#
A0099, Dako Cytomation, 1/500), mouse anti-villin (made in our
lab, 1/800), rabbit anti-chromogranin (cat# 20086, Immunostar,
1/200) and rabbit anti-mucin2 antibody (a generous gift of Dr
Hansson, Goteborg University, 1/200). Identification of goblet
cells on frozen sections was performed using Ulex Europeus
Agglutinin (UEA) coupled to Cy3 (1/50) (Sigma). For fluorescence
staining, nuclei were stained with DAPI. Cy3 or Alexa Fluor 633-
coupled secondary antibodies (Invitrogen) were detected by
compound epifluorescent and light microscopy or by an Apotome
Microscope. Photomicrographic images were processed using
Adobe Photoshop, with parallel images processed identically.
LacZ staining was carried out as described in Barker et al. [2].
In short, intestines were fixed for 2 hours on ice in 1% PFA, 0.2%
glutaraldehyde, and 0.02% NP40 in PBS, washed twice in PBS,
and subsequently stained overnight in 5 mmol/L K3FE(CN)6,
5 mmol/L K4FE(CN)6.3H2O, 2 mmol/L MgCl2, 0.02% NP40,
and 1 mg/mL X-gal in PBS. After staining, tissues were washed
twice in PBS and post-fixed overnight at 4uC in 4% PFA. LacZ-
positive cells were counted on several stretches of proximal
intestine totaling between 400 and 1000 crypts. The number of
tracing events was counted at the most proximal part of intestines
at different time points. At least 2 mice per time point were
analyzed. Other organs were snap-frozen in OCT without
fixation. Frozen sections were then fixed in 0.7% PFA, 0.05%
glutaraldehyde, and 0.02% NP40 in PBS at room temperature for
15 minutes, washed twice in PBS and incubated in X-gal solution
as described above.
For in situ hybridization, the proximal small intestine was
dissected and post-fixed overnight by immersion in 4% PFA, then
cryoprotected in 30% sucrose in 4% PFA and sectioned in the
transverse plane on a Leica sledge cryomicrotome at 40 mm (Leica
Microsystems, Germany). Sections were then mounted on slides
and processed for non-radioactive in situ hybridization as
described previously with minor modifications [40]. RNA probes
complementary to mouse Notch1 and Notch2 cDNA were prepared
and labeled with digoxigenin-11-UTP. Sections were analyzed
using a Zeiss AxioImager fitted with a Zeiss AxioCam MRc5
digital camera. Images were captured using AxioVision AC
software (Zeiss) and assembled using Adobe Photoshop.
Lineage Analysis and Notch inhibition. For lineage
analysis in the intestine, four week-old mice, including control
mice, received one single intra-peritoneal injection of
tamoxifen (ICN) (50 or 5 mg/Kg of mouse body weight) and
were analyzed at the indicated chase time points. To confirm
the absence of leakiness of the new transgenic lines, we
analyzed Notch(1–2)-CreERT2
SAT/+; R26R/+ and N(1–2)-
CreERT2
SAT/+;R 2 6
mTmG/+ mice without tamoxifen admi-
nistration and found no LacZ nor GFP staining in these
control mice. For expression analysis in other organs we used a
single intra-peritoneal injection of 4-Hydroxytamoxifen (4-
OHT) (50 mg/kg of mouse body weight).
Pharmacological inhibition of Notch signaling in Hes1-
EmGFP
SAT mice was achieved by intraperitoneal administration
of the c-secretase inhibitor dibenzazepine (DBZ: 20 mM/kg body
weight in 0.5% HPMC, 0.1% w/v NP40 in water; Calbiochem).
Adult mice were injected with DBZ for 4 consecutive days and
analyzed 3–4 days after the last injection.
Evaluation of stem cell replacement rate. To fit the data
for monoclonal conversion (Fig. 3E), we used the equations
associated with the neutral drift theory [25,30]. In our case,
however, we do not include any transit time, since we are counting
cells directly from crypts longitudinal sections. We assumed that
there are 16 stem cells/crypt, and that what we call a fully labeled
crypt has at least 14 labeled stem cells; this arbitrary cutoff affects
the results only marginally. The stem cell renewal rate, which
defines the only relevant time for monoclonal conversion, was then
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NonLinearModelFit function in Mathematica: l=1.3260.05/
days (P,10
25) [25,30]. Using this parameter, we generated the
expected theoretical curve for the fraction of marked crypts in time
(Figure 3F).
Supporting Information
Figure S1 Targeting of Notch(1–4) loci and expression
of the four Notch receptor paralogues. A) Schematic
representation of the knock-in strategy. The targeting allele
contains the CreERT2 gene and a polyadenylation signal (pA)
placed in frame with the start codon of each Notch gene, replacing
much of the ORF. In each of the four N(1–4)-CreERT2
SAT
knock-in (KI) strains, one allele of the targeted locus expresses the
CreERT2 fusion protein under the control of the corresponding
Notch paralogue promoter. Blue boxes represent exons. B–K)
Frozen sections labeled by X-gal (blue) showing the expression
pattern of N1-CreERT2
SAT/+; R26R/+ (B,F), N2-CreERT2
SAT/
+;R26R/+ (C,G), N3-CreERT2
SAT/+;R26R/+ (D,H,J) and N4-
CreERT2
SAT/+;R26R/+ (E,I,K) in adult mouse liver (B–E), heart
(F–I,K) and brain (J) 24 h after 4-OHT administration. Notch2 is
the most abundant paralogue in the liver (C). Notch3 is expressed
in mural cells of small and medium size penetrating arteries in the
brain (J,J9). Notch4 is expressed in endothelial cells of the heart
(K). Counterstain: Nuclear Fast Red (B–I) eosin (K). Scale bars:
50 mm in B–J, 25 mmi nK .
(TIF)
Figure S2 Notch1 expression in the mouse intestine
present a descending gradient. X-gal stained whole mounts
segments of duodenum (A), jejunum (B), ileum (C) and colon (D) of
N1-CreERT2
SAT/+;R26R/+ mice 21 days after tamoxifen
administration shows a drastic decrease in labeled crypt-villus
units in the distal parts of the intestine. Scale bar: 1 mm.
(TIF)
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